Literature DB >> 7995933

Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.

P A Morton1, M L Zacheis, K S Giacoletto, J A Manning, B D Schwartz.   

Abstract

The intracellular trafficking, proteolysis, and dissociation of invariant chain (li) associated with nascent class II molecules was examined in B-lymphoblastoid cells. Metabolic labeling and Percoll gradient centrifugation was used to assess the kinetics of delivery and processing of class II-li complexes within the endocytic pathway. Catabolism of class II-li complexes rapidly followed their delivery from post-Golgi compartments to dense lysosome-like compartments distinct from early and late endosomes. Direct peptide binding assays revealed that class II molecules associated with even small N-terminal fragments of li failed to bind peptide. Cysteine protease inhibitors alone blocked li proteolysis/dissociation and accumulation of class II-li biosynthetic intermediates within lysosome-containing compartments. Active-site labeling of cysteine proteases in B cells was used to identify cysteine proteases capable of mediating li proteolysis within endosomal compartments. Our results indicate rapid, possibly direct, transport of nascent class II-li complexes from the Golgi/trans-Golgi network to dense lysosomal compartments wherein cysteine protease(s), likely including cathepsin B, mediate complete removal of li. Inhibition of cysteine protease activity results in the accumulation of incompletely processed class II-li complexes, which lack peptide binding ability, within lysosomal compartments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7995933

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.

Authors:  V Brachet; G Péhau-Arnaudet; C Desaymard; G Raposo; S Amigorena
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators.

Authors:  Dorothy D Pless; Gordon Ruthel; Emily K Reinke; Robert G Ulrich; Sina Bavari
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.

Authors:  J Deussing; W Roth; P Saftig; C Peters; H L Ploegh; J A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.

Authors:  H J Hansen; G L Ong; H Diril; A Valdez; P A Roche; G L Griffiths; D M Goldenberg; M J Mattes
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

5.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

6.  Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines.

Authors:  G L Ong; D M Goldenberg; H J Hansen; M J Mattes
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

7.  Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.

Authors:  J V Peppard; A K Knap
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

8.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

9.  Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

Authors:  B B Gelman; D A Wolf; M Rodriguez-Wolf; A B West; A K Haque; M Cloyd
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

10.  Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum.

Authors:  Hein Sprong; Sophie Degroote; Tommy Nilsson; Masao Kawakita; Nobuhiro Ishida; Peter van der Sluijs; Gerrit van Meer
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.